Study [SU.VI.MAX] study / subjects / design / samples / assays

Basic properties of your study This page shows the basic information about your study, as well as information on the authorizations.

Publications

  • Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome.
    Phillips CM, Goumidi L, Bertrais S, Field MR, McManus R, Hercberg S, Lairon D, Planells R, Roche HM
  • Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome.
    Phillips CM, Goumidi L, Bertrais S, Ferguson JF, Field MR, Kelly ED, Peloso GM, Cupples LA, Shen J, Ordovas JM, McManus R, Hercberg S, Portugal H, Lairon D, Planells R, Roche HM

Contacts

  • Ryan, Miriam
    Data Submission

Authorization

Public Design
Yes
Readers
helen.roche
catherine.phillips
rosario.lombardo
Writers
miriam.ryan
Study title
LIPGENE-SUVIMAX PROGRAM
Template
Intervention/Observation study
title
LIPGENE-SUVIMAX PROGRAM
description
A prospective nested case-control genetic study of women aged 35-60 years and men aged 45-60 years recruited from the LIPGENE-SU.VI.MAX study. LIPGENE is an FP6 program entitled "Diet, genomics and the metabolic syndrome: an integrated nutrition, agro-food, social and economic analysis" . SU.VI.MAX participants (n=13,000) were studied over 8 years from 1994 to 2002.
code
SU.VI.MAX
startDate
1994-01-01 00:00:00.0
Study type
Human Intervention
Principle Investigator
Prof. Helen Roche
Objectives
Prospective population based cohort study Primary-prevention trial designed to evaluate the effect of antioxidant supplementation
Central conclusion
Proof of concept: Gene: Nutrient interactions
Institute
Trinity College DUblin UMR-INSERM U476 Marseille UMR-INSERM U557 Paris Hitachi Europe Ltd Dublin
Collaborators involved
Dr. Denis Lairon Marseille, Dr. Catherine Phillips
Consortium
not defined

back to list